FMSNYSEServices-Misc Health & Allied Services, NECAlso trades as FMCQF
Fresenius Medical Care AG
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$21.94−0.23 (-1.04%)
Close on Oct 19, 2026
- Market cap
- $5.89B
- P/E (TTM)
- –
- Dividend yield
- –
Fresenius Medical Care AG revenue by segment
By business segment
| Revenue | Q3 16 | Q2 16 | Q1 16 | Q3 15 | Q2 15 | Q1 15 | Q4 14 | Q3 14 | Q2 14 | Q1 14 | Q4 13 | Q3 13 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Segment Total [Member] | – | – | – | – | $4.19B | $3.95B | $4.30B | $4.10B | $3.82B | $3.56B | $3.86B | $3.66B | – | – |
| North America [Member] | – | – | – | – | – | $2.77B | – | $2.71B | $2.52B | $2.39B | – | $2.44B | – | – |
| International [Member] | – | – | – | – | – | – | – | $1.39B | $1.30B | $1.16B | – | $1.22B | – | – |
| Corporate1 [Member] | – | – | – | – | $5.00M | $7.14M | – | $14.58M | $14.93M | $8.51M | – | $5.37M | – | – |
| LA [Member] | – | – | – | – | – | $197.98M | – | – | – | $185.77M | – | – | – | – |
| EMEA [Member] | – | – | – | – | – | $629.01M | – | – | – | $732.34M | – | – | – | – |
| AP [Member] | – | – | – | – | – | $353.04M | – | – | – | $242.78M | – | – | – | – |
| EMEA | – | – | – | – | $667.66M | – | – | – | $789.64M | – | – | – | – | – |
| Asia Pacific | – | – | – | – | $376.12M | – | – | – | $308.52M | – | – | – | – | – |
| North America | – | – | – | – | $2.95B | – | – | – | $2.52B | – | – | – | – | – |
| Latin America | – | – | – | – | $202.84M | – | – | – | $198.46M | – | – | – | – | – |
| Operating income | Q3 16 | Q2 16 | Q1 16 | Q3 15 | Q2 15 | Q1 15 | Q4 14 | Q3 14 | Q2 14 | Q1 14 | Q4 13 | Q3 13 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Segment Total [Member] | – | – | – | – | $645.22M | $583.71M | – | $681.72M | $643.72M | $516.01M | – | $619.99M | – |
| North America [Member] | – | – | – | – | – | $340.08M | – | $413.20M | $400.71M | $335.56M | – | $415.53M | – |
| International [Member] | – | – | – | – | – | – | – | $268.52M | $243.01M | $180.45M | – | $204.46M | – |
| Corporate1 [Member] | – | – | – | – | -$98.26M | -$79.31M | – | -$91.80M | -$87.45M | -$71.11M | – | -$62.73M | – |
| LA [Member] | – | – | – | – | – | $17.86M | – | – | – | $18.56M | – | – | – |
| EMEA [Member] | – | – | – | – | – | $141.26M | – | – | – | $127.80M | – | – | – |
| AP [Member] | – | – | – | – | – | $84.51M | – | – | – | $34.09M | – | – | – |
| EMEA | – | – | – | – | $134.24M | – | – | – | $168.30M | – | – | – | – |
| Asia Pacific | – | – | – | – | $67.03M | – | – | – | $55.04M | – | – | – | – |
| North America | – | – | – | – | $428.23M | – | – | – | $400.71M | – | – | – | – |
| Latin America | – | – | – | – | $15.71M | – | – | – | $19.67M | – | – | – | – |
By product or service
By region
| Revenue | Q3 16 | Q2 16 | Q1 16 | Q3 15 | Q2 15 | Q1 15 | Q4 14 | Q3 14 | Q2 14 | Q1 14 | Q4 13 | Q3 13 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Segments Total | $4.60B | $4.42B | $4.20B | $4.23B | $4.19B | $8.15B | – | $4.23B | – | – | – | – | 99.9% | +8.7% |
| North America Segment | $3.30B | $3.17B | $3.04B | $3.01B | $2.95B | $5.72B | – | $3.01B | – | – | – | – | 71.8% | +9.5% |
| EMEA Segment | $675.33M | $676.34M | $630.79M | $658.88M | $667.66M | $1.30B | – | $658.88M | – | – | – | – | 14.7% | +2.5% |
| Asia-Pacific Segment | $427.23M | $396.76M | $374.34M | $377.98M | $376.12M | $729.16M | – | $377.98M | – | – | – | – | 9.3% | +13.0% |
| Latin America | $191.72M | $175.03M | $153.29M | $175.72M | $202.84M | $400.82M | – | $175.72M | – | – | – | – | 4.2% | +9.1% |
| Corporate [Member] | $2.70M | $3.52M | $2.11M | $4.59M | $5.00M | $12.14M | – | $4.59M | – | – | – | – | 0.1% | -41.3% |
From the segment and revenue-disaggregation notes of Fresenius Medical Care's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.